Hi Sol,
The share price appears to be consolidating around this level although wouldn't be surprised to see it drift lower in the next few weeks in absence of further news. Did you gleam any additional insights from Megan Baldwin's Bioshares conference presentation? Looks like it was a very good turn out in terms of delegates.
Cheers
Yehudi
Ann: Opthea reports positive data from Phase 1 wet AMD Trial-OPT.AX, page-9
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
0.020(2.42%) |
Mkt cap ! $1.040B | |||
| Open | High | Low | Value | Volume |
| 82.0¢ | 85.5¢ | 80.5¢ | $1.108M | 1.338M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 121666 | 84.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |